Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6MOG

Dimeric DARPin C_R3

6MOG の概要
エントリーDOI10.2210/pdb6mog/pdb
分子名称DARPin C_R3, 1,2-ETHANEDIOL, TRIETHYLENE GLYCOL, ... (4 entities in total)
機能のキーワードdarpin, biosynthetic protein
由来する生物種synthetic construct
タンパク質・核酸の鎖数2
化学式量合計35901.07
構造登録者
Jude, K.M.,Mohan, K.,Garcia, K.C. (登録日: 2018-10-04, 公開日: 2019-06-05, 最終更新日: 2024-04-03)
主引用文献Mohan, K.,Ueda, G.,Kim, A.R.,Jude, K.M.,Fallas, J.A.,Guo, Y.,Hafer, M.,Miao, Y.,Saxton, R.A.,Piehler, J.,Sankaran, V.G.,Baker, D.,Garcia, K.C.
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis.
Science, 364:-, 2019
Cited by
PubMed Abstract: Although tunable signaling by G protein-coupled receptors can be exploited through medicinal chemistry, a comparable pharmacological approach has been lacking for the modulation of signaling through dimeric receptors, such as those for cytokines. We present a strategy to modulate cytokine receptor signaling output by use of a series of designed C2-symmetric cytokine mimetics, based on the designed ankyrin repeat protein (DARPin) scaffold, that can systematically control erythropoietin receptor (EpoR) dimerization orientation and distance between monomers. We sampled a range of EpoR geometries by varying intermonomer angle and distance, corroborated by several ligand-EpoR complex crystal structures. Across the range, we observed full, partial, and biased agonism as well as stage-selective effects on hematopoiesis. This surrogate ligand strategy opens access to pharmacological modulation of therapeutically important cytokine and growth factor receptor systems.
PubMed: 31123111
DOI: 10.1126/science.aav7532
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.21 Å)
構造検証レポート
Validation report summary of 6mog
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon